Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. - Wikidata - awgldk - TriplyDB

Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

http://www.wikidata.org/entity/Q37337539

about

Obesity: "priming" the lung for injury Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD)Metabolic hormones, apolipoproteins, adipokines, and cytokines in the alveolar lining fluid of healthy adults: compartmentalization and physiological correlates Adipokines in inflammation and metabolic disease New insight into adiponectin role in obesity and obesity-related diseases.Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.Pulmonary and cardiac function in asymptomatic obese subjects and changes following a structured weight reduction program: a prospective observational study.Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Plasma Adiponectin, clinical factors, and patient outcomes during the acute respiratory distress syndrome.Cavin1; a regulator of lung function and macrophage phenotype.Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia Unrecognized glucose intolerance is common in pulmonary arterial hypertension Adiponectin in cardiovascular inflammation and obesity Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome.Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation.Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.Adiponectin and cardiovascular health: an update Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?Adiponectin action: a combination of endocrine and autocrine/paracrine effects.Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.Metabolic Dysfunction in Pulmonary Arterial Hypertension.Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.Scleroderma-related lung disease: are adipokines involved pathogenically?PPARgamma as a potential therapeutic target in pulmonary hypertension.PPARgamma activation: a potential treatment for pulmonary hypertension.Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.A process-based review of mouse models of pulmonary hypertension.Experimental and transgenic models of pulmonary hypertension.Single Microfluidic Electrochemical Sensor System for Simultaneous Multi-Pulmonary Hypertension Biomarker Analyses.Vascular remodeling mediated by Angptl2 produced from perivascular adipose tissue.Hemodynamic improvement of pulmonary arterial hypertension after bariatric surgery: potential role for metabolic regulation.Adiponectin levels are elevated in patients with pulmonary arterial hypertension.

P2860

Q27012995-9D772F78-ADDA-4C9F-9153-C7BD7149E65F Q28390687-70E0C4AC-E0E1-4314-81AF-C28E46E95D84 Q28545780-FBACE788-BE00-48B0-A1B9-CCA63D1AFDF2 Q29620456-5A7CBA69-21FC-4909-8046-95CC80867BC6 Q33943727-2A8AD0C9-9BBD-43A7-9E0E-0F2F5CC35DC5 Q34118474-C774F4EB-ABC4-4759-9396-CB7B5818A1AE Q34178976-4360FD46-2D82-4AA1-AD14-DCC1BD68A37C Q34184850-149A7558-44CC-4670-B549-36717E0C82DC Q34214907-22F260D6-C581-48C6-99F2-3268107B083B Q34245617-3AD282F5-37B4-43BF-9137-78BA9244214D Q34258758-662A8F59-4C96-4B8D-8E6B-3AF83A4C9E30 Q34698258-DF3D3312-1806-4767-904F-9FAC629C8C9B Q34782576-3390AB9B-2E22-4204-8C6E-465DEF5C5C59 Q35085796-A0B36BBD-B149-44B6-8B94-A9FBBD65A556 Q35219362-4D529E44-15FC-40EB-83B7-8E1E5890618D Q35219809-66E811B4-FF17-46D8-8E78-CBA3D6AE76A0 Q35354138-847B2B19-8A05-45DC-92D8-14AE39745C5A Q35601475-9F7F554C-D6CF-4E36-BEE6-713C3BEB9659 Q35658773-918C8309-81B2-449E-9181-547074DB0311 Q35665717-16235EFF-51CC-46BA-89B2-9685E1B326AF Q35859734-2FA9DA81-64EB-4FFB-8029-CB28FF4B5997 Q35896190-D41FC1C3-9409-4201-8D57-5EBF23825861 Q35971216-6E71FA76-5797-46CE-B729-04C48EFEF178 Q36074375-22C96109-9B84-43E7-9AD0-DAC2A06397DF Q36444135-D82AFB90-51EE-40E9-BD93-2D6FF8329E3B Q36694821-3D8FF070-70EC-4B4E-A68B-E08F06264DD5 Q36825335-C56DF9BF-1F7C-476B-9301-284A05A542F0 Q36888302-82206E99-F0FF-446F-A785-1B15BB9D3A16 Q36989465-108772C4-99C9-4193-9FDD-3E2E7C21C0C8 Q37408223-673A6D4C-CC07-488F-9F5C-A7B066FAB6E9 Q37689190-A9B285E8-504F-4BC3-AB89-8699EF4D8483 Q37725468-DA144FE0-32FF-40CF-84C2-574C2802AB0E Q37768336-E33E4015-4FB3-4626-9D6E-858257D15388 Q37972596-4A01EFDD-ED83-44CD-A166-2ABFB7C31273 Q38078369-90518022-7010-4FB3-80ED-323368E13F9A Q38112056-9ED61D3F-C274-4F08-93BA-A3B77305433C Q41308651-BE245B18-1703-45C9-AA55-92F72DA3099C Q42730442-CF90AD2D-89B5-47F7-9E79-3CF29F3FC025 Q43242175-0D244FFB-423E-4C8C-B96C-598BA441B3DA Q44876073-C1D22F2C-9693-4FF8-AD54-87B68F55217D

P2860

Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

http://www.wikidata.org/entity/Q37337539

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@en

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@nl

type

label

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@en

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@nl

prefLabel

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@en

Adiponectin deficiency: a mode ...... th pulmonary vascular disease.

@nl

P1433

Q37337539-6ECCBAA0-5FE9-4FA3-8033-90538F173BAC

P1476

Q37337539-FCA7E753-2FF4-48EA-9521-1335E853BDF3

P2093

Q37337539-3F72264C-8AD5-47DC-8E2D-1ADCEA091FED

Q37337539-5F1A18E1-4CF0-4B10-AE1D-A89087A114C4

Q37337539-8D03BF1E-284F-494A-9E03-DFBF244F909D

Q37337539-96173BEC-C12D-4EAD-B66D-6BE55A65C2E9

Q37337539-C936BA0A-163D-447B-A31E-BDFEA216282E

Q37337539-F03C2CD2-11A5-4169-BD5A-2B34F29D6EAD

Q37337539-FCEC9562-9A6E-4E7D-8D44-ADFDBF39B56A

P2860

Q37337539-05083323-E7C2-418E-987B-57D9A95E35AC

Q37337539-1D31827E-6FBF-4756-A643-FCC19E9AA713

Q37337539-1E208BB0-EE59-4B18-92B3-459109ECF4EC

Q37337539-25E1A8CB-CB37-462D-8648-1C4C2A0C9FA8

Q37337539-3684378B-09CB-49FE-96F3-9ECD72823C43

Q37337539-368A1C4E-6D3C-425B-B24B-1721C28FF34E

Q37337539-50A28B48-49C9-41B5-A105-18A58238FF4A

Q37337539-51CB94EF-2564-4160-BF27-DE374D02F292

Q37337539-53CCEB4A-CE11-48C9-9F78-03601CE09A99

Q37337539-609C2546-6793-46E8-B295-D0B3B73376C9

P304

Q37337539-F0DB2ABA-8499-4D28-B726-B183B2C47323

P31

Q37337539-2171724F-B7B1-4E77-BD55-759073820205

P356

Q37337539-3F7EF01A-CDAE-4744-A683-51FC86F9D113

P433

Q37337539-CE7B5563-34CA-4A06-A5EE-81C3EB7FCE65

P478

Q37337539-12491ECB-31F2-43FD-B2AF-E79652783403

P50

Q37337539-45C1C004-336A-4F3A-9EBA-9BC5C456A2FD

Q37337539-C951266E-C572-4D68-A429-046823F3624F

P577

Q37337539-FB830810-3304-4D3B-88DF-E362631C677C

P5875

Q37337539-050D6873-B285-431E-AC25-DEFE0D271297

P698

Q37337539-6713ADC1-A0FD-4CF3-ADB8-DC6C5B3A0AEB

P921

Q37337539-66490500-93C1-4C0F-AB99-AB0CE6F70EF2

P932

Q37337539-A905EA7C-42BA-4546-AF61-4CA2B675F5BE

P356

AJPLUNG.90599.2008

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Adiponectin deficiency: a mode ...... ith pulmonary vascular disease

@en

P2093

Christopher A Fiack

http://www.w3.org/2001/XMLSchema#string

Daniel Dwyer

http://www.w3.org/2001/XMLSchema#string

Kaori Sato

http://www.w3.org/2001/XMLSchema#string

Kenneth Walsh

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Ross Summer

http://www.w3.org/2001/XMLSchema#string

Yasumasa Ikeda

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

ACRP30, a new hormone controlling fat and glucose metabolism.

Inflammation in pulmonary arterial hypertension.

Obesity, adiponectin and vascular inflammatory disease.

P304

L432-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.90599.2008

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P50

Harrison W Farber

P577

2009-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26325267

http://www.w3.org/2001/XMLSchema#string

P698

19561137

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2739777

http://www.w3.org/2001/XMLSchema#string